Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984 and has grown to become a leading producer of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulations, and other healthcare products.
Revenue from Operations was ₹1,146 Cr, up 15% year on year, primarily due to higher Paracetamol API sales in the US. The revenue share from the United States increased to 49.4% in Q3 FY23, up from 43.1% the previous year. Active pharmaceutical ingredients (API), pharmaceutical formulation intermediates (PFI), and finished dosages each contribute 35.8%, 18.6%, and 45.6% of revenue from operations. The Consolidated Net Profit was ₹124.32 crore, up from ₹100.88 crore in the same quarter last year. This quarter’s earnings per share was ₹5.10.
While operating cash flow is quite healthy at ₹161 Cr, free cash flow has been impacted at (₹32.5) Cr due to additional deployments of ₹50 Cr in our new expansion plan with green initiatives in Kakinada and ₹42.5 Cr for land acquisition in Vishakhapatnam. ROCE increased to 25.6% from 21.2% year on year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,